Full Name | Cristine Fetzer |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | Unit 33100, Apo, Armed Forces Europe |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336904762 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PTL19643 (Colorado) | Primary |
Mailing Address | Practice Location Address |
---|---|
Cristine Fetzer, Psc 10 Box 38, Apo, AE 09142-0001 Ph: () - | Cristine Fetzer, Unit 33100, Apo, AE 09180-3100 Ph: (314) 590-5762 |
News Archive
Stock futures fell late Tuesday and early Wednesday as voters re-elected President Barack Obama, even as some business and labor groups cheered his victory.
An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.
"Abortion was one of the most contentious issues in this debate from the very beginning, more than a year ago. A longstanding law — the Hyde Amendment — bars federal funds from being used to pay for elective abortions. It's an agreement between anti-abortion and pro-abortion rights lawmakers that is so delicate it could balance on a pin."
A research group at Umeå University in Sweden has managed to capture and describe a protein structure that, until now, has been impossible to study. The discovery lays the base for developing designed enzymes as catalysts to new chemical reactions for instance in biotechnological applications.
The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and C-terminal fragments of FGF23 in human serum and plasma. The FGF23 ELISA assay complements the existing Biomedica assays directed against chronic kidney disease - mineral and bone disorder (CKD-MBD) in a growing collection.
› Verified 8 days ago
Joseph Frjelich, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Phone: 314-590-2368 | |
Emily Ward, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Usahc Vicenza, Apo, AE 09630 Phone: 339-619-7896 | |
Jenna Marie Boyd, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 3215, Apo, AE 09094 Phone: 314-479-2609 | |
Dr. Ashlyn Owens Hull, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: U.s. Army Health Clinic Hohenfels Unit 28216 Hohenfels,, Apo, AE 09173 Phone: 314-590-3300 | |
Maria Lebron, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Psc 94, Apo, AE 09824 Phone: 011-903-163223380 | |
Dr. Nicoleta Grigoras, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-8298 | |
Susan Kay Oppliger, PHYSICAL THERAPIST Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Attn:mceul-dccs (credentials), Apo, AE 09180 Phone: 011-496-78366710 |